Navigation Links
Medtronic Inc. Cancels Cardiovascular and Orthopedic Contracts With Novation
Date:2/24/2011

IRVING, Texas, Feb. 24, 2011 /PRNewswire/ -- Novation, the leading health care supply contracting company, announced today that Medtronic Inc. has cancelled five contracts with Novation that cover cardiovascular and orthopedic products.  Novation is owned by VHA Inc. and the University HealthSystem Consortium (UHC), and VHA and UHC members represent $2 billion in annual purchases for Medtronic in these product categories. Novation has been in constant contact with Medtronic and has made every effort to maintain member value in these high cost categories. Medtronic stated in a letter to Novation that the company wanted to manage their business relationships with hospitals locally, rather than through a national GPO contract.

"This move will likely raise costs for member organizations by eliminating the price protection that members benefit from through Novation's national agreements," said Pete Allen, senior vice president of sourcing operations at Novation. "In addition, through our contracts members generate cooperative returns, and have more favorable terms and conditions. The contracts also protect members from pricing confidentiality clauses, eliminate freight fees, and mandate that new technology is added to contracts when the technologies are released."

In response to Medtronic's action, 16 of the leading U.S. not-for-profit hospitals and academic medical centers sent an open letter to the chairman and chief executive officer of Medtronic Inc., stating their 'extreme disappointment' with Medtronic during this time of unprecedented cost pressures. Hospitals in this country are facing more than $155 billion in reduced government reimbursement over the next ten years; placing an unprecedented burden on their existing fragile financial viability.  Dissolution of the Novation contracts will force health care organizations to develop individual agreements with Medtronic in order to obtain discounted pricing and new terms and conditio
'/>"/>

SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
2. PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
3. Renhuang Cancels Third Quarter 2010 Conference Call
4. Essilor Cancels Four Million Shares
5. Reportlinker Adds Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
6. MAQUET Cardiovascular Launches New VASOVIEW 6 PRO Endoscopic Vessel Harvesting System
7. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
8. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
9. Reportlinker Adds Europe Cardiovascular Devices Market Outlook to 2016
10. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
11. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  Valeant Pharmaceuticals International, ... today announced it has completed the sale to Galderma ... Dysport owned or held by Valeant for $1.4 billion ... Nestle S.A, which recently completed its acquisition of Galderma. ... divestiture of our products to a company that is ...
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation ... of directors has approved a quarterly dividend of $0.275 (27.5 ... is payable on August 1, 2014, to holders of record ... CVS Caremark is dedicated to helping people on ... company in the United States . Through ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 25, 2011 Reportlinker.com announces that a new ... Overview of the Western European ... http://www.reportlinker.com/p0363315/-Overview-of-the-Western-European-Peripheral-Interventional-Devices-Market.html The objective of ... of the largely stable European peripheral interventional devices ...
... 25, 2011 Aerocrine, Inc., an innovative medical technology ... airways, has selected R&J Public Relations, LLC of Bridgewater, ... will conduct strategic public relations for the Aerocrine brand; ... first and only hand-held device available to measure exhaled ...
Cached Medicine Technology:Reportlinker Adds Overview of the Western European Peripheral Interventional Devices Market 2R&J Public Relations Named Agency of Record for Aerocrine, Inc. 2
(Date:7/11/2014)... July 11, 2014 Butler Mobility has recently ... Inclined Platform Lifts . Previously the two standard colors ... new beautiful earth tone colors as standard colors at no ... in the home but will enhance the beauty of the ... any home color scheme or individual décor. , The new ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- People with the ... condition called peripheral artery disease (PAD), a new study suggests. ... supply blood to the limbs, most often the legs. The ... narrowing of the arteries throughout the body. People with PAD ... Researchers analyzed data from nearly 6,800 people with PAD who ...
(Date:7/11/2014)... 2014 Volunteers from Scientology Churches ... this week with drug education lectures, forums and conferences, ... in cities around the world. , Drug abuse is ... on Drug Abuse, abuse of alcohol and illicit drugs ... lost work, decreased productivity and healthcare. , In ...
(Date:7/11/2014)... York, NY (PRWEB) July 11, 2014 ... http://www.gynecaremorcellatorlawsuit.com/ ) investigation, Bernstein Liebhard LLP has been ... Food & Drug Administration’s (FDA) Obstetrics and ... explore ways to mitigate the cancer risks associated ... invasive gynecological surgeries. According to a report published ...
(Date:7/11/2014)... The Europe Well Intervention Market report defines ... analysis and revenue forecast. The well intervention services market in ... 2013 to $3.4 billion by 2018, at a CAGR of ... of the Europe Well Intervention Market report, to get an ... glimpse of the segmentation in the Europe well intervention market, ...
Breaking Medicine News(10 mins):Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2Health News:Poor More Prone to Leg Circulation Trouble 2Health News:Scientologists Taking Action against Drug Abuse 2Health News:Scientologists Taking Action against Drug Abuse 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 3
... published in the,April 2008 issue of The American Journal ... and all-cause mortality, an,unusual finding for which the researchers ... analyzed data from the Physicians,Health Study I which followed ... fact is, healthy adults can continue to enjoy eggs ...
... muscle-thickening disorder may also identify children at risk , , ... gene mutations responsible for cardiac hypertrophy (thickening of the ... cases of this rare but life-threatening condition in children, ... up in children who had no family history of ...
... study shows similar results , , WEDNESDAY, April 9 (HealthDay News) ... artery to the brain to prevent a stroke -- is ... a surgery called endarterectomy, a study shows. , But endarterectomy ... continue to be the treatment of choice for the 70 ...
... An aging population and a shortage of,healthcare ... can monitor,patients remotely, process data, and even alert ... new generation patient monitoring (PM) systems,earned an estimated ... this could more than double in five years, ...
... Launched earlier this month,as a members-only benefit, ... to its AVMA Collections to the general public,expanding ... and up-to-date,veterinary medical information., AVMA Collections was ... organized by topic/subject from the Journal of the,American ...
... Reade Holdings, Inc. today,announced that David D,Arezzo, Senior Vice ... to assume a senior management,position at a large southwest ... 17, 2008., The Company has initiated a search ... swiftly to identify another high caliber executive,to join the ...
Cached Medicine News:Health News:Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 2Health News:Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption 3Health News:Gene Mutations for Rare Heart Disease Also Found in Kids 2Health News:Stenting as Good as Surgery for Stroke Prevention 2Health News:New Patient Monitoring Devices Handle More Than Just Vital Signs 2Health News:AVMA Opens Online Resource to General Public 2Health News:Duane Reade Holdings, Inc. Announces Resignation of Chief Marketing Officer 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: